Active ingredient description

Anecortave, a synthetic cortisone, has been shown to have antiangiogenic properties that have been established in multiple experimental models of angiogenesis. Anecortave is under investigation to treat exudative age-related macular degeneration (AMD). Although similar in chemical structure to the corticosteroid hydrocortisone acetate, it possesses no glucocorticoid activity.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
S Sensory organs → S01 Ophthalmologicals → S01L Ocular vascular disorder agents → S01LA Antineovascularisation agents
Discover more medicines within S01LA02

Structural formula

Graphic representation of the active ingredient's molecular structure

Chemical formula: C₂₃H₃₀O₅
Molecular mass: 344.451 g/mol

External identifiers

CAS Substance: 10184-70-0
CAS Substance: 7753-60-8
DrugBank Drug: DB12081
KEGG Drug: D01733
PubChem Compound: 7074810
UNII Identifier: R5Y8O51589


Anecortave is an active ingredient of these brands:

South Africa (ZA)

While we strive to include the brand names of medicines across all countries, our index remains incomplete. Therefore, it is possible that this medicine may also be marketed under different names in other countries.